NK cell-based tumor immunotherapy

Area of Science:

• Immunology
• Oncology
• Nanotechnology

Background:

• Natural killer (NK) cells are crucial for eliminating virus-infected and tumor cells, especially in hematological cancers.
• Their therapeutic potential for solid tumors is limited by the immunosuppressive tumor microenvironment, causing NK cell inactivation, poor expansion, and reduced infiltration.
• This necessitates strategies to overcome these suppressive effects for effective solid tumor treatment.

Purpose of the Study:

• To review the mechanisms of NK cell activation and inhibition within solid tumors.
• To summarize recent advancements in NK cell-based immunotherapy enhanced by nanomaterials.
• To discuss the challenges and future opportunities for clinical translation of NK cell therapies.

Main Methods:

• Review of scientific literature on NK cell function in solid tumors.
• Analysis of studies employing nanotechnology to augment NK cell immunotherapy.
• Synthesis of information on NK cell activation, inhibition, and nanomaterial applications.

Main Results:

• Solid tumors create a complex immunosuppressive microenvironment that impairs NK cell function.
• Nanomaterials show potential in overcoming these suppressive mechanisms, improving NK cell activity, expansion, and tumor infiltration.
• Diverse nanomaterial strategies are being explored to boost NK cell-based cancer immunotherapy.

Conclusions:

• Overcoming the immunosuppressive tumor microenvironment is key to successful NK cell therapy for solid tumors.
• Nanotechnology offers promising avenues to enhance NK cell immunotherapy efficacy.
• Further research and clinical translation are needed to realize the full potential of NK cell-based cancer treatments.